Paolo Fundaro - Net Worth and Insider Trading

Paolo Fundaro Net Worth

The estimated net worth of Paolo Fundaro is at least $76 Million dollars as of 2024-07-16. Paolo Fundaro is the Director, 10% Owner of Intercept Pharmaceuticals Inc and owns about 4,021,028 shares of Intercept Pharmaceuticals Inc (ICPT) stock worth over $76 Million. Details can be seen in Paolo Fundaro's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Paolo Fundaro has not made any transactions after 2020-08-17 and currently still holds the listed stock(s).

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Paolo Fundaro

To

Paolo Fundaro Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paolo Fundaro owns 1 companies in total, including Intercept Pharmaceuticals Inc (ICPT) .

Click here to see the complete history of Paolo Fundaro’s form 4 insider trades.

Insider Ownership Summary of Paolo Fundaro

Ticker Comapny Transaction Date Type of Owner
ICPT Intercept Pharmaceuticals Inc 2020-08-17 director & 10 percent owner

Paolo Fundaro Latest Holdings Summary

Paolo Fundaro currently owns a total of 1 stock. Paolo Fundaro owns 4,021,028 shares of Intercept Pharmaceuticals Inc (ICPT) as of August 17, 2020, with a value of $76 Million.

Latest Holdings of Paolo Fundaro

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ICPT Intercept Pharmaceuticals Inc 2020-08-17 4,021,028 19.00 76,399,532

Holding Weightings of Paolo Fundaro


Paolo Fundaro Form 4 Trading Tracker

According to the SEC Form 4 filings, Paolo Fundaro has made a total of 2 transactions in Intercept Pharmaceuticals Inc (ICPT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Intercept Pharmaceuticals Inc is the sale of 1,500,000 shares on August 17, 2020, which brought Paolo Fundaro around $71 Million.

Insider Trading History of Paolo Fundaro

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paolo Fundaro Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Paolo Fundaro Ownership Network

Ownership Network List of Paolo Fundaro

No Data

Ownership Network Relation of Paolo Fundaro

Insider Network Chart

Paolo Fundaro Owned Company Details

What does Intercept Pharmaceuticals Inc do?

Who are the key executives at Intercept Pharmaceuticals Inc?

Paolo Fundaro is the director & 10 percent owner of Intercept Pharmaceuticals Inc. Other key executives at Intercept Pharmaceuticals Inc include EVP & Chief Financial Officer Andrew Saik , President & R&D and CMO M Michelle Berrey , and Chief Accounting Officer Rocco Venezia .

Intercept Pharmaceuticals Inc (ICPT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Intercept Pharmaceuticals Inc (ICPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intercept Pharmaceuticals Inc (ICPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Intercept Pharmaceuticals Inc (ICPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intercept Pharmaceuticals Inc Insider Transactions

No Available Data

Paolo Fundaro Mailing Address

Above is the net worth, insider trading, and ownership report for Paolo Fundaro. You might contact Paolo Fundaro via mailing address: C/o Genextra S.p.a.,, Via G. De Grassi, 11, Milan L6 20123.

Discussions on Paolo Fundaro

No discussions yet.